References
- Adams, C. E., Bartsch, S., & Fenton, M. K. (2004). Publishing patterns of the four drugs most commonly reported in schizophrenia trials. Schizophrenia Research, 67, 140 (abstract).
- Almond, S., & O'Donnell, O. (1998). Cost analysis of the treatment of schizophrenia in the UK: a comparison of olanzapine and haloperidol. Pharmacoeconomics, 13, 575–588.
- Barrowclough, C., & Wykes, T. (2004). Family intervention in schizophrenia. In D. J. Castle, D. L. Copolov, & T. Wykes (Eds.), Pharmacological and Psychosocial Treatments in Schizophrenia (pp. 123–136). London: Taylor and Francis.
- Carr, V., Neil, A., Halpin, S., & Holmes, S. (2002). Costs of psychosis in Australia. Canberra: Commonwealth Department of Health and Ageing.
- Castle, D. J. (2000). Comments on the UK700 case management trial. British Journal of Psychiatry, 177, 370–371 (letter).
- Gilbert, M., Miller, K., Berk, L., Ho, V., & Castle, D. (2003). The scope for psychosocial treatments for psychosis: an overview of Collaborative Therapy. Australasian Psychiatry, 11, 220–224.
- Glazer, W. M., & Johnstone, B. M. (1997). Pharmacoeconomic evaluation of antipsychotic therapy for schizophrenia. Journal of Clinical Psychiatry, 58\(suppl 10), 50–54.
- Green, M. F. (1998). Schizophrenia from a neurocognitive perspective. Allyn and Bacon: Needham Heights, MA.
- Hogarty, G. E., Anderson, C. M., Reiss, D. J., Kornblith, S. J., Greenwald, D. P., Ulrich, R. F., & Carter, M. (1991). Family psychoeductaion, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. 2) 2-year effects of a controlled study on relapse and adjustment. Archives of General Psychiatry, 48, 340.
- Jablensky, A., McGrath, J. J., Herrman, H., et al. (2000). Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Australian and New Zealand Journal of Psychiatry, 34, 221–236.
- Kemp, R., Kirov, G., Hayward, P. & David, A. (1998). Randomised controlled trial of compliance. British Journal of Psychiatry, 172, 413–419.
- Preston, N., & Fazio, S. (2000). Establishing the efficacy and cost effectiveness of community intensive case management of long-term mentally ill: a matched control group study. Australian and New Zealand Journal of Psychiatry, 34, 114–121.
- Scott, J., & Sensky, T. (2003). Methodological aspects of randomized controlled trials of psychotherapy in primary care. Psychological Medicine, 33, 191–196.
- Sensky, T., Turkington, D., Kingdon, D., Scott, J. L., Scott, J., Siddle, R., O'Carroll, M. & Barnes, T. R. (2000). A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry, 57, 165–172.
- Streiner, D. L. (2002). The 2 'Es' of research: efficacy and effectiveness trials. Canadian Journal of Psychiatry, 47, 552–556.
- UK-700 Group. (2002). Cost effectiveness of intensive v. standard case management for severe psychotic illness. British Journal of Psychiatry, 176, 537–543.
- Wykes, T., & Castle, D. (2004). Psychological approaches to the management of persistent delusions and hallucinations. In D. J. Castle, D. L. Copolov, & T. Wykes (Eds.), Pharmacological and psychosocial treatments in schizophrenia (pp. 23–34). London: Taylor and Francis.